Literature DB >> 8418200

Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation.

D E Mosier1, K L Stell, R J Gulizia, B E Torbett, G L Gilmore.   

Abstract

The autosomal recessive scid mutation results in defective immunoglobulin and T cell receptor gene rearrangement. The scid mutation occurred in the allotype congenic C.B-17 line, and up to 25% of C.B-17 scid mice spontaneously produce both T cells and immunoglobulin, a phenotype known as "leaky." Moreover, introduction of neonatal T cells into C.B-17 scid mice leads to immunoglobulin production by 100% of animals. We have produced mice homozygous for both the scid and beige mutations. By contrast with C.B-17 scid mice, BALB/c scid.beige mice have a < 2% incidence of "leakiness." This percentage does not increase with age, and introduction of neonatal T cells fails to rescue immunoglobulin production. This suggests that a gene (or genes) closely linked to the beige locus regulates B and/or T cell development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418200      PMCID: PMC2190863          DOI: 10.1084/jem.177.1.191

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

Authors:  W Schuler; I J Weiler; A Schuler; R A Phillips; N Rosenberg; T W Mak; J F Kearney; R P Perry; M J Bosma
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

2.  Occurrence of mature B (IgM+, B220+) and T (CD3+) lymphocytes in scid mice.

Authors:  A M Carroll; R R Hardy; M J Bosma
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

3.  The beige mutation in the mouse selectively impairs natural killer cell function.

Authors:  J Roder; A Duwe
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

4.  Distribution of anomalous lysosomes in the beige mouse: a homologue of Chediak-Higashi syndrome.

Authors:  C Oliver; E Essner
Journal:  J Histochem Cytochem       Date:  1973-03       Impact factor: 2.479

5.  The scid mutation in mice causes a general defect in DNA repair.

Authors:  G M Fulop; R A Phillips
Journal:  Nature       Date:  1990-10-04       Impact factor: 49.962

6.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

7.  Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).

Authors:  K Dorshkind; S B Pollack; M J Bosma; R A Phillips
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

8.  The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells.

Authors:  J E Riggs; R S Stowers; D E Mosier
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

9.  Evidence of functional lymphocytes in some (leaky) scid mice.

Authors:  G C Bosma; M Fried; R P Custer; A Carroll; D M Gibson; M J Bosma
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency.

Authors:  J E Riggs; R S Stowers; D E Mosier
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

View more
  20 in total

1.  Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.

Authors:  Hung-Ming Lam; Holly M Nguyen; Eva Corey
Journal:  Methods Mol Biol       Date:  2018

Review 2.  Human allograft rejection in humanized mice: a historical perspective.

Authors:  Michael A Brehm; Leonard D Shultz
Journal:  Cell Mol Immunol       Date:  2012-02-13       Impact factor: 11.530

3.  Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models.

Authors:  R Minelli; S Occhipinti; C L Gigliotti; G Barrera; P Gasco; L Conti; A Chiocchetti; G P Zara; R Fantozzi; M Giovarelli; U Dianzani; C Dianzani
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

Review 4.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

5.  Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy.

Authors:  Manikkam Suthanthiran; Minoru Hojo; Mary Maluccio; Daniel J Boffa; Fu L Luan
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

6.  Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

Authors:  T Warner; E Balish
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

7.  Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains of mice bearing the IL2rgamma(null) mutation.

Authors:  Michael A Brehm; Amy Cuthbert; Chaoxing Yang; David M Miller; Philip DiIorio; Joseph Laning; Lisa Burzenski; Bruce Gott; Oded Foreman; Anoop Kavirayani; Mary Herlihy; Aldo A Rossini; Leonard D Shultz; Dale L Greiner
Journal:  Clin Immunol       Date:  2010-01-21       Impact factor: 3.969

Review 8.  The SCID mouse: relevance as an animal model system for studying human disease.

Authors:  E A Hendrickson
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

9.  Development of grafted gld cells in athymic and euthymic recipients.

Authors:  N Rosenblatt; K U Hartmann; F Loor
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

10.  An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse.

Authors:  Sylvia E Le Dévédec; Wies van Roosmalen; Naomi Maria; Max Grimbergen; Chantal Pont; Reshma Lalai; Bob van de Water
Journal:  Clin Exp Metastasis       Date:  2009-05-24       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.